TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
20 hedge funds and large institutions have $988K invested in Titan Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
+5
Holders Change %
+33.33%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
3
Reduced
3
Closed
2
Calls
$741K
Puts
$999K
Net Calls
-$258K
Net Calls Change
-$494K
Top Buyers
1 |
![]()
Group One Trading
Chicago,
Illinois
|
+$216K |
2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$119K |
3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$69K |
4 |
Bank of New York Mellon
New York
|
+$54K |
5 |
UBS Group
Zurich,
Switzerland
|
+$51.9K |
Top Sellers
1 |
TI
tru Independence
Portland,
Oregon
|
-$11.5K |
2 |
Citadel Advisors
Miami,
Florida
|
-$9.58K |
3 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$7K |
4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.4K |